Dr. Gervino has trained generations of physicians, medical students and allied health professionals in the field of stress testing. Many have become leaders at regional, national and international levels. Accomplished physicians and health care professionals have done sabbaticals in Dr. Gervino’s lab refining their skills in stress testing of high-risk patients. He repeatedly gives lectures on stress testing to house staff and attending physicians and has developed the “BI Modified Bruce & Gervino Protocols” for patients with limited functional capacity, allowing for appropriate titration of physiologic responses prior to the patient reaching their functional limitations. In recognition of his expertise in the area of stress testing complex patients, he served on an AHA/ACC committee with a group of prestigious cardiologists as the only non-physician on “who is competent to perform cardiac stress testing?” He has also served on other national and regional committees and at the Baim Institute helping to set policy regarding stress testing.

Dr. Gervino’s stress protocols have been used in national and international clinical research trials which include BiosenseDMR Angiogenesis National Project, Chiron FGF0002 Angiogenesis National Trial, Biosense DIRECT Angiogenesis National-International Project, Cardiac Dimension AMADEUS, COMPETENT, TITAN CVP-0855-01 National-International Trials and Baxter Autologous ACT CD34+ Cells National Trial.

He has performed Cardiopulmonary Stress Tests for the past 40 years on thousands of healthy and diseased patients to determine their metabolic response to exercise. He has also served as a peer reviewer for Harvard Catalyst Clinical and Translational Science Center as Scientific and Resource Reviewer on adult cardiology and the Core Lab Director for stress testing at Harvard Clinical Research Institute, now Baim Institute, evaluating outcomes of clinical trials. He has collaborated in multi-centered national and international trials in cardiology, neurology and diabetes. He is consulted by industry as an expert in presentations to FDA panels based on clinical stress test results.